Steve Nowicki
Corporate Officer/Principal at Fresenius Kabi Pharmaceuticals Holding LLC
Profile
Steve Nowicki is currently the Vice President-Manufacturing at Fresenius Kabi Pharmaceuticals Holding LLC.
Previously, he worked as a Senior Manager-Operations Management at Cardinal Health, Inc. He holds a graduate degree from North Carolina State University and an undergraduate degree from Purdue University.
Steve Nowicki active positions
Companies | Position | Start |
---|---|---|
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Corporate Officer/Principal | 2011-03-01 |
Former positions of Steve Nowicki
Companies | Position | End |
---|---|---|
CARDINAL HEALTH, INC. | Corporate Officer/Principal | - |
Training of Steve Nowicki
North Carolina State University | Graduate Degree |
Purdue University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CARDINAL HEALTH, INC. | Distribution Services |
Private companies | 1 |
---|---|
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Health Technology |
- Stock Market
- Insiders
- Steve Nowicki